Hot Pursuit     19-Jan-15
Unichem Laboratories drops after poor Q3 outcome
Unichem Laboratories fell 3.95% to Rs 222.60 at 13:01 IST on BSE after net profit fell 97.2% to Rs 2.06 crore on 0.1% decline in net sales to Rs 262.89 crore in Q3 December 2014 over Q3 December 2013.

The Q3 result was announced on Saturday, 17 January 2015.

Meanwhile, the S&P BSE Sensex was up 142.68 points or 0.51% at 28,264.57.

On BSE, so far 47,000 shares were traded in the counter as against average daily volume of 46,591 shares in the past one quarter.

The stock hit a high of Rs 225.90 and a low of Rs 212 so far during the day. The stock had hit a 52-week low of Rs 182 on 14 July 2014. The stock had hit a 52-week high of Rs 267.90 on 15 December 2014.

The stock had underperformed the market over the past one month till 16 January 2015, sliding 5.81% compared with Sensex's 5.01% rise. The scrip had also underperformed the market in past one quarter, advancing 6.38% as against Sensex's 8.16% rise.

The small-cap pharmaceutical company has equity capital of Rs 18.15 crore. Face value per share is Rs 2.

Unichem Laboratories is an international, integrated, specialty pharmaceutical company.

Previous News
  Unichem Laboratories reports consolidated net loss of Rs 0.67 crore in the June 2023 quarter
 ( Results - Announcements 14-Jul-23   18:40 )
  Unichem Lab rises on receiving USFDA nod for anticonvulsant drug
 ( Hot Pursuit - 23-Aug-22   11:20 )
  Unichem Laboratories to conduct AGM
 ( Corporate News - 30-Jun-22   11:21 )
  Unichem Laboratories to declare Quarterly Result
 ( Corporate News - 19-Oct-23   12:22 )
  Unichem Laboratories receives USFDA approval for Carbamazepine Tablets
 ( Corporate News - 23-Aug-22   11:34 )
  Unichem receives USFDA approval for Quetiapine ER Tablets
 ( Corporate News - 16-Aug-22   10:50 )
  Unichem Labs drops 22% in six days
 ( Hot Pursuit - 05-Dec-22   13:12 )
  Unichem Laboratories to table results
 ( Corporate News - 20-May-22   16:02 )
  Unichem Laboratories receives USFDA approval for Guanfacine Tablets
 ( Corporate News - 04-Mar-21   17:30 )
  Unichem Laboratories receives ANDA approval for Tolterodine Tartrate Tablets
 ( Corporate News - 06-Aug-20   14:22 )
  Unichem Laboratories reports consolidated net loss of Rs 14.60 crore in the December 2019 quarter
 ( Results - Announcements 03-Feb-20   16:48 )
Other Stories
  Avantel Q2 PAT jumps 42% YoY to Rs 23 cr
  05-Oct-24   17:03
  Equitas SFB total deposits jump 29% YoY in Q2 FY25
  05-Oct-24   16:28
  Ujjivan SFB total deposits rises 17% in Q2 FY25
  05-Oct-24   15:34
  L&T Finance retail disbursements jump 12% YoY in Q2 FY25
  05-Oct-24   14:31
  Bandhan Bank records over 21% YoY jump in loan book during Q2 FY25; deposits at Rs 1.42 lakh crore
  05-Oct-24   13:32
  Lupin's Pune-based biotech facility gets 5 observations from US FDA
  05-Oct-24   13:20
  Macrotech Developers pre-sales jumps 21% YoY in Q2 FY25
  05-Oct-24   09:04
  UCO Bank’s total advances jump 19% YoY in Q2 FY25
  04-Oct-24   15:15
  Vakrangee Ltd leads losers in 'A' group
  04-Oct-24   15:00
  Kamdhenu Ventures Ltd leads losers in 'B' group
  04-Oct-24   14:45
Back Top